Equillium Inc. buy BiotechBee
Start price
17.02.24
/
60%
€2.69
Target price
30.09.25
€4.00
Performance (%)
-18.44%
End price
03.03.24
€2.19
Summary
This prediction ended on 03.03.24 with a price of €2.19. The prediction for Equillium Inc. disappointed with a performance of -18.44%. BiotechBee has a follow-up prediction for Equillium Inc. where he still thinks Equillium Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Equillium Inc. | - | - |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
According to BiotechBee what are the pros and cons of Equillium Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Equillium Inc. diskutieren
Buy mit Kursziel 4,0
In the thread Trading Equillium Inc.
Buy beendet
Current prediction by BiotechBee for Equillium Inc.
Equillium Inc.
Start price
Target price
Perf. (%)
€2.19
03.03.24
03.03.24
€6.00
31.05.26
31.05.26
-69.68%
13.08.24
13.08.24
Could be very worthwhile Investment >20% year